CTI Biopharma, lascia il numero uno James Bianco dopo 25 anni
CTI BioPharma annuncia revoca sospensione clinica totale su Pacritinib
Ultime Notizie Cti Biopharma News
Our commitment to finding better treatment options for patients is our top priority. 2015 Annual Report
CTI BIOPHARMA CORP.
CTI BIOPHARMA CORP.
Azioni CTI BioPharma: Quotazione, Andamento e Previsioni
CTI BioPharma | Targeted Blood Cancer Therapies | Home
10 milioni per il Trisenox, Cti BioPharma vola - MilanoFinanza News
Filed by Cell Therapeutics, Inc. Pursuant to Rule 425 under the Securities Act of 1933 Subject Company: Cell Therapeutics, Inc.
Azioni CTi Biopharma in Borsa | Quotazione NASDAQ: CTIC - Investing.com
CTI BioPharma Announces Retirement Of President And CEO
INDEX METHODOLOGY Solactive Pharma Breakthrough Value Index
SEC Filing | CTI BioPharma Corp.
CTI BioPharma | Targeted Blood Cancer Therapies | Home
CTI BioPharma | Targeted Blood Cancer Therapies | Home
CTI BioPharma | Targeted Blood Cancer Therapies | Home
EMERGE EXPAND EVOLVE
CTI BioPharma | Targeted Blood Cancer Therapies | Home
Document
